DK1293198T3 - Anordning til transdermal indgivelse til behandling af urinkanallidelser - Google Patents

Anordning til transdermal indgivelse til behandling af urinkanallidelser

Info

Publication number
DK1293198T3
DK1293198T3 DK01121687T DK01121687T DK1293198T3 DK 1293198 T3 DK1293198 T3 DK 1293198T3 DK 01121687 T DK01121687 T DK 01121687T DK 01121687 T DK01121687 T DK 01121687T DK 1293198 T3 DK1293198 T3 DK 1293198T3
Authority
DK
Denmark
Prior art keywords
group
substituted
alkyl
phenyl
halogen atoms
Prior art date
Application number
DK01121687T
Other languages
Danish (da)
English (en)
Inventor
Frank Dr Dressen
Dietrich Schacht
Hans-Michael Dr Wolff
Original Assignee
Sanol Arznei Schwarz Gmbh
Kissei Pharmaceutical
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sanol Arznei Schwarz Gmbh, Kissei Pharmaceutical filed Critical Sanol Arznei Schwarz Gmbh
Application granted granted Critical
Publication of DK1293198T3 publication Critical patent/DK1293198T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
    • A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
    • A61K9/7038—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer
    • A61K9/7046—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds
    • A61K9/7053—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds obtained by reactions only involving carbon to carbon unsaturated bonds, e.g. polyvinyl, polyisobutylene, polystyrene
    • A61K9/7061—Polyacrylates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/403—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Dermatology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines Containing Plant Substances (AREA)
  • External Artificial Organs (AREA)
DK01121687T 2001-09-14 2001-09-14 Anordning til transdermal indgivelse til behandling af urinkanallidelser DK1293198T3 (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP01121687A EP1293198B1 (fr) 2001-09-14 2001-09-14 Système d'administration transdermal pour le traitement de désordres du tract urinaire

Publications (1)

Publication Number Publication Date
DK1293198T3 true DK1293198T3 (da) 2005-06-06

Family

ID=8178599

Family Applications (1)

Application Number Title Priority Date Filing Date
DK01121687T DK1293198T3 (da) 2001-09-14 2001-09-14 Anordning til transdermal indgivelse til behandling af urinkanallidelser

Country Status (9)

Country Link
US (1) US20050226919A1 (fr)
EP (1) EP1293198B1 (fr)
AT (1) ATE288745T1 (fr)
DE (1) DE60108870T2 (fr)
DK (1) DK1293198T3 (fr)
ES (1) ES2237515T3 (fr)
HK (1) HK1054327B (fr)
PT (1) PT1293198E (fr)
WO (1) WO2003024432A2 (fr)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2006038619A1 (fr) * 2004-10-06 2006-04-13 Kissei Pharmaceutical Co., Ltd. Préparation thérapeutique visant à éliminer l’étape de transition vers le traitement opératoire de l'hypertrophie prostatique
ATE415153T1 (de) * 2005-06-06 2008-12-15 Nitto Denko Corp Pharmazeutische zusammensetzung zur perkutane absorption unter verwendung von einem metalchlorid, vorzugsweise natriumchlorid, zur vorbeugung von kohäsionsschwäche
JP5813652B2 (ja) * 2010-10-28 2015-11-17 久光製薬株式会社 経皮吸収型製剤

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE126434T1 (de) * 1991-06-10 1995-09-15 Sanol Arznei Schwarz Gmbh Nitroglycerin-pflaster und verfahren zu seiner herstellung.
EP0600675B1 (fr) * 1992-12-02 1998-07-08 Kissei Pharmaceutical Co., Ltd. Composés indoliniques pour le traitement de la dysurien
IL120302A0 (en) * 1996-03-27 1997-06-10 Pfizer Use of alpha1-adrenoreceptor antagonists in the prevention and treatment of benign prostatic hyperplasia
IL120303A0 (en) * 1996-03-27 1997-06-10 Pfizer Use of alpha1-adrenoreceptor antagonists in the prevention and treatment of cancer
US5843472A (en) * 1997-02-28 1998-12-01 Cygnus, Inc. Transdermal drug delivery sytem for the administration of tamsulosin, and related compositions and methods of use
AU3011299A (en) * 1998-03-23 1999-10-18 Merck & Co., Inc. Combination therapy for the treatment of benign prostatic hyperplasia
US6541669B1 (en) * 1998-06-08 2003-04-01 Theravance, Inc. β2-adrenergic receptor agonists

Also Published As

Publication number Publication date
HK1054327A1 (en) 2003-11-28
ATE288745T1 (de) 2005-02-15
PT1293198E (pt) 2005-06-30
HK1054327B (zh) 2005-07-29
DE60108870D1 (de) 2005-03-17
ES2237515T3 (es) 2005-08-01
US20050226919A1 (en) 2005-10-13
WO2003024432A2 (fr) 2003-03-27
DE60108870T2 (de) 2005-07-28
WO2003024432A3 (fr) 2003-09-04
EP1293198A1 (fr) 2003-03-19
EP1293198B1 (fr) 2005-02-09

Similar Documents

Publication Publication Date Title
AP9801302A0 (en) Indole compounds as anti-inflammatory/analgesic agents..
NO20071042L (no) 5-substituerte 2-fenylaminobenzamider som MEK-inhibitorer
DE60233884D1 (de) 4(4-alkoxy-3-hydroxyphenyl)-2-pyrrolidon-derivate als pde-4-hemmer zur behandlung von neurologischen syndromen
EA201100189A1 (ru) Гетероарильные производные в качестве ингибиторов dgat1
DE60026318D1 (de) Isoxazolin derivate und herbizide, die diese als aktiven bestandteil enthalten
CY1109519T1 (el) Κεκορεσμενες και ακορεστες 3-πυριδυλο-βενζοκυκλοαλκυλομεθυλαμινες για τη θεραπεια πονων, καταθλιψεων και καταστασεων φοβου
PE20040728A1 (es) Inhibidores de caspasa
DE60222596D1 (de) Fettsäureverbindungen und deren herstellung und verwendungen
DE69914478D1 (de) Oxazolidinon-derivate als antibiotika, verfahren zu ihrer herstellung und diese derivate enthaltende pharmazeutische zusammensetzungen
SE0400043D0 (sv) New compounds
NO953575D0 (no) Farmasöytiske forbindelser
ATE338047T1 (de) Stickstoffbasierte camptothecin-derivate
DK1293198T3 (da) Anordning til transdermal indgivelse til behandling af urinkanallidelser
ATE301125T1 (de) Heterocyclische verbindungen und mittel, die die hirnfunktion verbessern und als wirkstoff diese verbindungen enthalten
DK1156058T3 (da) Fremgangsmåde til fremstilling af (E,Z) 3-(2-aminoethoxyimino)-androstan-6,17-dion og analoger deraf
EP1829861A3 (fr) Dérivés estérifiés de la pyrrolidine effectifs comme antagonistes de l'oxytocine
SI1806136T1 (sl) Medicinski sestavek za preprečevanje prehoda na operativno zdravljenje prostatične hipertrofije
DK1205476T3 (da) Fremgangsmåde til syntese af N-(mercaptoacyl)-aminosyrederivater ud fra alfa-substituerede acrylsyrer
ATE293591T1 (de) Neue n-(2-phenyl-3-aminopropyl)naphtamide
ATE457023T1 (de) Alkylpyridiniumdicyanamide als polare lösungsmittel
EA201070197A1 (ru) Производные 1-оксо-изоиндолин-4-карбоксамидов и 1-оксо-1,2,3,4-тетрагидроизохинолин-5-карбоксамидов, способ их получения и применение в терапии
HK1106502A1 (fr)
ATE225785T1 (de) Tetrazolylalkyl-indolderivate als entzündungshemmende und analgetische mittel